The Next Wave for Virus Testing Stocks (HOLX, ALST, FLGT)

0
While vaccines are rolling out rapidly around the developed world, and uptake is expected to produce some version of herd immunity within...

DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology

0
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...

Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.

0
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....

Popular News

MAKE IT MODERN

LATEST REVIEWS

Will Election Spur Clean Oil Stocks? (VLO, PQEFF, CLNE)

0
This Tuesday’s election in the US will have many dynamic impacts across a number of different industries. If the polls are only a little...

MAKE IT MODERN

PERFORMANCE TRAINING

Humanigen Inc (NASDAQ:HGEN) Demonstrates Improved Survival Of COVID-19 Patients In Phase 3 Clinical Trial...

0
Humanigen Inc (NASDAQ:HGEN) reported positive topline results of lenzilumab, which is tested in phase 3 clinical trials in hospitalized COVID-19 patients. The patients showed...

Phathom Pharmaceuticals Inc. (NASDAQ: PHAT) Announce Positive PHALCON-EE Study Results Of Vonoprazan in Erosive...

0
Phathom Pharmaceuticals Inc. (NASDAQ: PHAT) announced that vonoprazan met the primary endpoints and core secondary superiority endpoints in PHALCON-EE, a vital third phase study...

Nektar Therapeutics (NASDAQ:NKTR) Reports Q3 2020 Financial Results And Bempegaldesleukin Development Updates

0
Nektar Therapeutics (NASDAQ:NKTR) has announced its Q3 2020 financial results for the period ended September 30, 2020. At the end of the quarter, the...

ISW Holdings Inc (OTCMKTS:ISWH), Telehealth, and the Distributed Model Revolution

0
There are a number of quote-unquote “revolutions” in play right now, mostly as collateral consequences of the global pandemic health crisis that has gripped...

Anavex Life Sciences Corp (NASDAQ:AVXL) Commences Phase 1 Clinical Study Of ANAVEX3-71: Expects First...

0
Anavex Life Sciences Corp (NASDAQ:AVXL) began phase 1 clinical study of innovative formulation ANAVEX3-71 by enrolling the first patient. The small molecule, which is...

MAKE IT MODERN

POPULAR

romabet mahbet پین باهیس bettingmagazine.org بت کارت یاس بت yekbet megapari onjabet alvinbet betboro betfa بت فوروارد 1xbet 1win betwinner 4shart.com 1xbetgiris.cam وان کیک بت وین بت ریتزوبت 1xbet-ir.com.co وان ایکس بت بت فوروارد